The Inhibitory Effects of Anti-ERC/Mesothelin Antibody 22A31 on Colorectal Adenocarcinoma Cells, within a Mouse Xenograft Model.

导出 OA

翻译打印收藏纠错

作者： Gentaro,Taniguchi ^[1] ; Kazunori,Kajino ^[2] ; Shuji,Momose ^[1] ; Harumi,Saeki ^[3] ; Liang,Yue ^[4] ; Naomi,Ohtsuji ^[3] ; Masaaki,Abe ^[1] ; Tomoyoshi,Shibuya ^[1] ; Akira,Orimo ^[3] ; Akihito,Nagahara ^[1] ; Sumio,Watanabe ^[2] ; Okio,Hino ^[1]

作者单位： Department of Molecular Pathology, Graduate School of Medicine, Juntendo University, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan. ^[1] Department of Gastroenterology, Faculty of Medicine, Juntendo University, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan. ^[2] Department of Human Pathology, Graduate School of Medicine, Juntendo University, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan. ^[3] Department of Pathology, Saitama Medical Center, Saitama Medical University, 1981 Kamoda, Kawagoe 350-8550, Japan. ^[4]

关键词 ERC anti-ERC antibody colorectal cancer mesothelin molecular targeting therapy

DOI 10.3390/cancers14092198

PMID 35565327

发布时间 2022-07-16

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交